Immunization

Nearly 80% of infants born in a California health system were exposed to nirsevimab or the maternal respiratory syncytial virus vaccine in 2023-2024, the first season in which they were available, according to study findings.

The most-read Healio Pediatrics story of 2024 was a Q&A with Lisa L. Abuogi, MD, MSc, FAAP, who co-authored the AAP’s policy statement in support of breastfeeding for parents with HIV.

Each cover of Healio | Infectious Disease News is topped by a feature story on an emerging topic in the field of ID.

The FDA accepted a biologics license application for Merck’s respiratory syncytial virus immunization, clesrovimab, the company announced Tuesday.

An experimental vaccine against malaria that uses live-attenuated Plasmodium falciparum malaria parasites showed promise in a small human challenge trial, researchers reported in The New England Journal of Medicine.

NEW YORK — In this video from the Infectious Diseases in Children Symposium, David W. Kimberlin, MD, provides an overview of the topics that were added to the 2024-2027 Red Book published earlier this year.

BOSTON — Vaccine hesitancy was less likely to occur in racially diverse vs. white patients, although this hesitancy was not significantly impacted by age, sex or language, according to a poster presentation here.

A combination of several factors makes it tough for providers to identify measles cases as the disease makes a comeback, according to experts.